Nourhan M.Aly

Quick facts

Marketed products

• Duraphat · Other
• Hypertonic Dextrose Solution
• MTA pulp dressing material · Dentistry / Endodontics
  MTA (Mineral Trioxide Aggregate) pulp dressing material promotes biocompatibility and hard tissue formation through alkaline pH and calcium ion release at the dentin-pulp interface.
• Topical Benzocaine 20% · Anesthesia / Pain Management
  Benzocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.

Phase 3 pipeline

• Sublingual Dexmedetomidine · Anesthesiology
  Dexmedetomidine is an alpha-2 adrenergic agonist that acts as a sedative and anxiolytic.

Phase 2 pipeline

• Atraumatic Restorative Treatment
• Blood clot scaffold
• Blood clot scaffold combined with PRF
• Nebulized Midazolam
• Papacarie · Other
• Resin modified glass ionomer cement

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Nourhan M.Aly portfolio CI brief
• Nourhan M.Aly pipeline updates RSS